611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Cancer
Resources
Basic InformationLatest News
Screening Often Misses Endometrial Cancer in Black WomenLong Distance to Care Can Mean Worse Outcomes for Young Cancer PatientsAlcohol Tied to 740,000 Cancer Cases Worldwide in 2020Cancer Survivors Fared Better Financially After ObamacarePandemic Delays in Screening Mean More Breast Cancer Deaths Ahead: StudyObese Men May Have Better Survival With Advanced Prostate CancerMost Cancer Screenings Make Big Rebound After Pandemic DeclineAdding MRI to Screening Can Cut Prostate Cancer Overdiagnosis in HalfU.S. Deaths From Cancer Continue to DeclineAlmost All Cancer Patients Respond Well to COVID-19 VaccinesCould Too Many Antibiotics Raise Your Odds for Colon Cancer?Too Little Sunlight, Vitamin D May Raise Colon Cancer RiskShining a Light on SunscreensGap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by EnoughCost a Barrier to Cervical Cancer Screening for Many U.S. WomenMost Americans Don't Follow Diets That Could Prevent CancerAHA News: Women With Heart Failure From Breast Cancer Treatment May Fare Better Than Previously ThoughtWomen's Cancer Screenings Plummeted During PandemicYoung Cancer Survivors Vulnerable to COVID, But Often Shun VaccineSome Myeloma Patients Get No Protection From COVID-19 VaccinesBlack Men Less Likely to Get Best Prostate Cancer TreatmentsCould Home Test for Colon Cancer Mean a Big Medical Bill to Come?Heart Failure Patients May Be at Higher Cancer RiskCould a DNA Blood Test Spot a Range of Hidden Cancers?For People With Heart Failure, Statins May Lower Cancer Risk TooMany 'High-Risk' Americans Unconcerned About Skin Cancer: PollSurvivors' Plasma Helps Blood Cancer Patients Battle COVID-19Race Doesn't Affect Risk for Genes That Raise Breast Cancer RiskHealthy Levels of Vitamin D May Boost Breast Cancer OutcomesStudy Pinpoints Cancer Patients at Highest Risk From COVIDCan You Keep Your Bladder After Bladder Cancer Strikes?Breast Cancer's Spread Is More Likely in Black Women, Study FindsNewly Approved Drug Fights Lung Cancer Tied to Certain GenesDrug Lynparza Could Help Fight Some Early-Stage Breast CancersTargeted Radiotherapy Might Help Men Battling Advanced Prostate CancerOut-of-Pocket Costs Delay Cancer Follow-Up Care, Even for the InsuredDon't Delay Lung Cancer Surgery, Study SuggestsModerate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: StudyFaulty Gene Could Raise Vulnerability to Asbestos-Linked CancerColonoscopy After 75: A Potential Lifesaver for MostBreast Cancer Treatments Don't Raise COVID RisksImmunotherapy Drug Can Beat Back Early-Stage Lung CancerKey Factors That Raise Your Odds for Early-Onset Colon CancerHPV Vaccination Is Lowering U.S. Cervical Cancer RatesAs Medicaid Access Expands, So Does Cancer SurvivalMS May Not Affect Breast Cancer PrognosisGet First Colonoscopy at 45, not 50: U.S. Expert PanelMelanoma Can Strike Your Nails: Here's How to CheckGene-Targeted Drug Shows Promise Against a Form of Pancreatic CancerObesity Raises Odds for Many Common Cancers
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Don't Delay Lung Cancer Surgery, Study Suggests

HealthDay News
by Robert Preidt
Updated: May 28th 2021

new article illustration

FRIDAY, May 28, 2021 (HealthDay News) -- Surgery soon after a diagnosis of early-stage lung cancer is crucial in reducing the risk of recurrence and death, a new study finds.

"Patients with early-stage cancer have the best chance for survival," said senior author Dr. Varun Puri, a thoracic surgeon and professor of surgery at Washington University School of Medicine in St. Louis. "That's why it's critical for patients to promptly seek treatment within 12 weeks after they've been diagnosed."

But some patients postpone surgery. They have a variety of reasons for doing so, including getting second opinions, economic or social factors, or even family events such as child's wedding or a vacation, researchers noted.

Since last year, concerns about contracting COVID-19 in the hospital also led patients to delay surgery.

But this study of more than 9,900 U.S. patients (average age: 67) with stage 1 non-small cell lung cancer who had surgery between October 2006 and September 2016 found that waiting more than 12 weeks after diagnosis with a CT scan was associated with increased odds of recurrence and death.

The majority (70%) of patients had surgery within 12 weeks. On average, those who had surgery within 12 weeks lived 7.5 months longer than those who did not -- 76.1 months versus 68.6 months.

Forty-two percent of patients had a recurrence of cancer in the six years after surgery, but it was more common in patients who had surgery after 12 weeks. Each week of delay was associated with a modest increase in the risk of recurrence, according to findings published May 27 in the journal JAMA Network Open.

"Physicians and patients want to know more about the safety of delaying surgery. The risks have been poorly understood because previous studies have used imprecise definitions for the date of cancer diagnosis. The goal of our study was to provide more uniform data, which we did by tracking patients from most recent CT scan diagnosis to day of surgery," Puri said in a university news release.

Lung cancer is the second most common type of cancer (after skin cancers) and the leading cause of cancer death in the United States. Non-small cell lung cancer accounts for 84% of all lung cancer cases and the five-year survival rate is 25%, according to the American Cancer Society.

More information

The American Lung Association has more on lung cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 27, 2021